Identification of enhanced cytokine generation following sepsis. Dream of magic bullet for mortality prediction and therapeutic evaluation

DARU, Journal of Pharmaceutical Sciences

Volumn 18, Issue 3, 2010, Pages 155-162

  Hamishehkar, H ^a,b   Beigmohammadi, M T ^c   Abdollahi, M ^d   Ahmadi, A ^e   Mahmoodpour, A ^c,e   Mirjalili, M R ^e   Abrishami, R ^a   Khoshayand, M R ^a   Eslami, K ^a   Kanani, M ^f   Baeeri, M ^d   Mojtahedzadeh, M ^a,e  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Sina hospital   (Iran)

^f MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

APACHE; IL 1 ; ; IL 6; Severe sepsis; SOFA; TNF

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APACHE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RESUSCITATION; SCORING SYSTEM; SEPSIS;

EID: 78149457918     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Angus D.C, Wax RS. Epidemiology of sepsis: an update. Crit Care Med, 2001; 29: S109-116.
2. Vincent J.L, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med, 1998; 26: 1793-1800.
3. Bozza F.A, Bozza P.T, Castro Faria Neto H.C. Beyond sepsis pathophysiology with cytokines: what is their value as biomarkers for disease severity? Mem Inst Oswaldo Cruz, 2005; 100 Suppl 1: 217-221.
4. Hadidi E, Mojtahedzadeh M, Paknejad M.H, Nikfar S, Zamani M.J, Sahraian M.A, Eftekhar B, Khajavi M.R, Najafi A, Ghaffarzadeh M, Eftekhari R, Soleimani V, Esmaily H, Rouini M.R, Abdollahi M. Alterations of blood IL-8, TGF-β1 and nitric oxide levels in relation to blood cells in patients with acute brain injury Therapy, 2006; 3: 6.
5. Nikbakht F.NH, Dabiri Sh. The effect of enalapril on inflammation and IL-1 and IL-8 production in chronic arthritis. Daru, 2007; 15: 6.
6. Dinarello C.A. Proinflammatory and anti-inflammatory cytokines as mediators in the pathogenesis of septic shock. Chest, 1997; 112: 321S-329S.
7. Dellinger R.P, Carlet J.M, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall J.C, Parker M.M, Ramsay G, Zimmerman J.L, Vincent JL, Levy M.M. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 2004; 32: 858-873.
8. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal- directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med, 2001; 345: 1368-1377.
9. Wunder C, Eichelbronner O, Roewer N. Are IL-6, IL-10 and PCT plasma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res, 2004; 53: 158-163.
10. Bozza F.A, Salluh J.I, Japiassu A.M, Soares M, Assis E.F, Gomes R.N, Bozza M.T, Castro-Faria-Neto H.C, Bozza P.T. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care, 2007; 11: R49.
11. Shapiro N.I, Trzeciak S, Hollander J.E, Birkhahn R, Otero R, Osborn T.M, Moretti E, Nguyen H.B, Gunnerson K.J, Milzman D, Gaieski D.F, Goyal M, Cairns C.B, Ngo L, Rivers E.P. A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med, 2009; 37: 96-104.
12. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 1992; 20: 864-874.
13. Oberholzer A, Oberholzer C, Moldawer L.L. Cytokine signaling-regulation of the immune response in normal and critically ill states. Crit Care Med, 2000; 28: N3-12.
14. Pinsky M.R, Vincent J.L, Deviere J, Alegre M, Kahn R.J, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest, 1993; 103: 565-575.
15. Oberholzer A, Souza S.M, Tschoeke S.K, Oberholzer C, Abouhamze A, Pribble J.P, Moldawer L.L. Plasma cytokine measurements augment prognostic scores as indicators of outcome in patients with severe sepsis. Shock, 2005; 23: 488-493.
16. Friedland J.S, Porter J.C, Daryanani S, Bland J.M, Screaton N.J, Vesely M.J, Griffin G.E, Bennett E.D, Remick D.G. Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit. Crit Care Med, 1996; 24: 1775-1781.
17. Gogos C.A, Drosou E, Bassaris H.P, Skoutelis A. Pro- versus anti-inflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic options. J Infect Dis, 2000; 181: 176-180.
18. Meenagh A, Williams F, Ross O.A, Patterson C, Gorodezky C, Hammond M, Leheny W.A, Middleton D. Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America. Hum Immunol, 2002; 63: 1055-1061.
19. Dimopoulou I, Orfanos S, Kotanidou A, Livaditi O, Giamarellos-Bourboulis E, Athanasiou C, Korovesi I, Sotiropoulou C, Kopterides P, Ilias I, Kanellakopoulou K, Armaganidis A. Plasma pro- and anti-inflammatory cytokine levels and outcome prediction in unselected critically ill patients. Cytokine, 2008; 41: 263-267.
20. Simon L, Gauvin F, Amre D.K, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis, 2004; 39: 206-217.